Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$686K Sell
4,682
-6
-0.1% -$1.09K 0.25% 57
2026
Q1
$690K Sell
4,688
-40
-0.8% -$6.5K 0.28% 57
2025
Q4
$922K Sell
4,728
-62
-1% -$14.8K 0.38% 45
2025
Q3
$1.35M Hold
4,790
0.58% 30
2025
Q2
$1.05M Sell
4,790
-1,687
-26% -$272K 0.5% 37
2025
Q1
$906K Sell
6,477
-1,098
-14% -$179K 0.48% 39
2024
Q4
$1.26M Sell
7,575
-39
-0.5% -$6.93K 0.71% 29
2024
Q3
$1.3M Hold
7,614
0.75% 31
2024
Q2
$1.08M Hold
7,614
0.66% 35
2024
Q1
$956K Buy
+7,614
New +$871K 0.64% 40

Other funds holding ORCL

Emprise Bank's ORCL Position: Q2 2026 in Review

Emprise Bank reduced its Oracle (ORCL) stake by 0.13% in Q2 2026, selling an estimated $1.09K and leaving 4,682 shares worth $686K. The position accounts for 0.25% of the portfolio, ranked #57.

Emprise Bank first reported a position in ORCL in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.35M in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Emprise Bank held 4,682 shares of Oracle worth $686K as of Q2 2026.
  • Emprise Bank sold 6 Oracle shares in Q2 2026, an estimated $1.09K.
  • Oracle made up 0.25% of Emprise Bank's portfolio in Q2 2026, its #57 holding.
  • Emprise Bank first reported a position in Oracle in Q1 2024 and has held it in 10 quarters since.
  • Emprise Bank's Oracle position peaked at $1.35M in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Emprise Bank's 13F filing for Q2 2026, filed 7 Jul 2026.